INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic Cancer

Conditions:   Pancreatic Cancer Non-resectable;   Pancreatic Cancer Metastatic Intervention:   Drug: INCMGA00012 (PD-1 antibody) Sponsors:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;   Incyte Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials